Cirrhosis/Liver Failure News

The American Gastroenterological Association published new clinical practice guidelines on palliative care management in patients with cirrhosis.

In this video exclusive, Pol Boudes, MD, chief medical officer of Galectin Therapeutics, spoke about NAVIGATEnash.com, a website for physicians and patients to get information on cirrhosis stemming from nonalcoholic steatohepatitis.

Versantis announced positive results from a phase 1b clinical trial of VS-01 in patients with decompensated cirrhosis.

Patients with cirrhosis prioritize early-detection over factors like convenience when it comes to hepatocellular carcinoma surveillance, according to study results.

Using transient elastography within 2 months of alcohol cessation was an effective method to rule out alcohol-related compensated advanced chronic liver disease, according to study results.

Using routine blood tests may identify patients at risk for advanced liver disease, according to results published in BMJ Open.

Nearly one in four patients admitted for decompensated cirrhosis globally have acute-on-chronic liver failure, according to study results.

Weight loss, intensive treatment of diabetes or prediabetic states and coffee or tea consumption may decrease the risk for alcohol-related cirrhosis, according to a study published in the American Journal of Gastroenterology.

Healio Gastroenterology presents the following reports on the most recent research in hepatology.

Patients with alcohol-related liver disease who survive for at least 1 year after diagnosis are at increased risk for cancer, according to study results.